Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Asthma
24%
Global Disease Burden
23%
Disease
22%
Prevalence
19%
Adverse Event
11%
Disease Exacerbation
10%
Bronchiectasis
10%
Antibiotics
9%
SARS Coronavirus
9%
Biological Marker
9%
Antibiotic Agent
9%
Sleep Disordered Breathing
8%
Pandemic
8%
Coronavirinae
8%
Life Expectancy
7%
Corticosteroid
6%
All Cause Mortality
6%
Glucocorticoid
6%
Cohort Study
6%
Mortality Rate
5%
Muscarinic Receptor Blocking Agent
5%
Dry Powder Inhaler
5%
Comorbidity
5%
Antiinfective Agent
5%
Glucocorticoid Receptor
5%
Respiratory Virus
5%
Randomized Controlled Trial
5%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
55%
Asthma
34%
COVID-19
31%
Meta-Analysis
28%
Global Disease Burden
18%
Prevalence
11%
Bronchiectasis
10%
Respiratory Disease
10%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
10%
Diseases
9%
Diagnosis
9%
Disease Exacerbation
9%
Life Expectancy
8%
Adverse Event
8%
Disability Adjusted Life Years
7%
Antibiotic Resistance
7%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Biological Marker
6%
Adolescent
6%
Mortality Rate
5%
Anti-biotics
5%
Antibiotics
5%
Eosinophil
5%
Infection
5%
Clinician
5%
Randomized Controlled Trial
5%
Nursing and Health Professions
Obstructive Lung Disease
17%
Bronchiectasis
10%
Asthma
7%
Confidence Interval
6%
Practice Guideline
5%
Antibiotic Agent
5%
